Skip to main content
. Author manuscript; available in PMC: 2025 Jan 1.
Published in final edited form as: Am J Med Genet B Neuropsychiatr Genet. 2023 Jul 17;195(1):e32952. doi: 10.1002/ajmg.b.32952

TABLE 1.

Descriptive statistics of gastrointestinal symptoms and polygenic scores across autism spectrum disorder cases and population controls, Study to Explore Early Development.

ASD (n = 564) POP (n = 715) p-value*
Any GI symptoms (n (%)) 187 (33.2%) 81 (11.3%) <0.00001
Specific GI symptoms (n (%))
 Vomiting 33 (5.9%) 6 (0.8%) <0.00001
 Diarrhea 50 (8.9%) 12 (1.7%) <0.00001
 Loose stools 76 (13.5%) 24 (3.4%) <0.00001
 Constipation 132 (23.4%) 54 (7.6%) <0.00001
 Loose stools alternating with constipation 71 (12.6%) 17 (2.4%) <0.00001
 Abdominal pain with meals 30 (5.3%) 13 (1.8%) 0.0006
 Abdominal pain relieved by defecation 42 (7.4%) 29 (4.1%) 0.0085
 Pain on stooling 72 (12.8%) 25 (3.5%) <0.00001
 Gas 86 (15.2%) 25 (3.5%) <0.00001
Male (n (%)) 453 (80.3%) 391 (54.7%) <0.00001
European ancestry (n [%]) 303 (53.7%) 501 (70.0%) <0.00001
Crohn’s disease PGSa (mean [SD]) −0.08 [1.04] 0.05 [0.97] 0.019
Ulcerative colitis PGSa (mean [SD]) −0.07 [1.04] 0.078 [0.98] 0.0093
Inflammatory bowel disease PGSa (mean [SD])a −0.08 [1.05] 0.07 [0.95] 0.0045

Abbreviations: ASD, autism spectrum disorder; GI, gastrointestinal; PGS, polygenic score; POP, population control.

a

Standardized PGS.

*

p-Value reflect univariate, unadjusted associations between GI symptom and ASD status from 2 sample z-test.